Disease-modifying therapies should be stopped in NMOSD patients in remission - Yes
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
Multiple sclerosis (Houndmills, Basingstoke, England) - 25(2019), 9 vom: 10. Aug., Seite 1217-1218 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shosha, Eslam [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 16.06.2020 Date Revised 16.06.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/1352458519829694 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM295235519 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM295235519 | ||
003 | DE-627 | ||
005 | 20231225083222.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/1352458519829694 |2 doi | |
028 | 5 | 2 | |a pubmed24n0984.xml |
035 | |a (DE-627)NLM295235519 | ||
035 | |a (NLM)30900952 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shosha, Eslam |e verfasserin |4 aut | |
245 | 1 | 0 | |a Disease-modifying therapies should be stopped in NMOSD patients in remission - Yes |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.06.2020 | ||
500 | |a Date Revised 16.06.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Immunologic Factors |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Multiple sclerosis (Houndmills, Basingstoke, England) |d 1997 |g 25(2019), 9 vom: 10. Aug., Seite 1217-1218 |w (DE-627)NLM09012992X |x 1477-0970 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2019 |g number:9 |g day:10 |g month:08 |g pages:1217-1218 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/1352458519829694 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2019 |e 9 |b 10 |c 08 |h 1217-1218 |